SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-024222
Filing Date
2021-05-03
Accepted
2021-05-03 16:01:42
Documents
41
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0321_lanternpharma.htm 10-Q 373572
2 CERTIFICATION f10q0321ex31-1_lantern.htm EX-31.1 10434
3 CERTIFICATION f10q0321ex31-2_lantern.htm EX-31.2 10508
4 CERTIFICATION f10q0321ex32-1_lantern.htm EX-32.1 3684
5 CERTIFICATION f10q0321ex32-2_lantern.htm EX-32.2 3681
  Complete submission text file 0001213900-21-024222.txt   1776182

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE ltrn-20210331.xml EX-101.INS 169797
7 XBRL SCHEMA FILE ltrn-20210331.xsd EX-101.SCH 24842
8 XBRL CALCULATION FILE ltrn-20210331_cal.xml EX-101.CAL 15662
9 XBRL DEFINITION FILE ltrn-20210331_def.xml EX-101.DEF 111618
10 XBRL LABEL FILE ltrn-20210331_lab.xml EX-101.LAB 216739
11 XBRL PRESENTATION FILE ltrn-20210331_pre.xml EX-101.PRE 117969
Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Filer) CIK: 0001763950 (see all company filings)

IRS No.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39318 | Film No.: 21883452
SIC: 2834 Pharmaceutical Preparations